Elagolix 68513-0039-09
- Manufacturer
- Abbvie Ireland Nl B.v.
- Dosage Form
- Tablet, Film Coated
- Product Type
- Drug For Further Processing
- Marketing Start
- January 22, 2018
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Elagolix | 200 mg/1 |
Selected Package
68513-0039-09Selected26000 TABLET, FILM COATED in 1 BOX (68513-0039-9)